Why spend money on something your going to put out of business? These companies will fall behind us and have to reinvent themselves or close. We don't lose but maybe we start a new catalyst to help improve the whole biopharma industry. Targeted medicine can take a huge step forward and everyone from the stockholders to the patients win.